DOYLE THOMAS JAMES 4
4 · Kura Oncology, Inc. · Filed Jan 31, 2024
Insider Transaction Report
Form 4
DOYLE THOMAS JAMES
SVP, Finance & Accounting
Transactions
- Sale
Common Stock
2024-01-29$17.80/sh−963$17,142→ 48,093 total - Sale
Common Stock
2024-01-29$17.80/sh−594$10,573→ 49,817 total - Sale
Common Stock
2024-01-29$17.80/sh−761$13,546→ 49,056 total
Holdings
- 500(indirect: By Spouse)
Common Stock
Footnotes (3)
- [F1]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 1/26/22.
- [F2]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/7/22.
- [F3]Sell-to cover for taxes associated with the vesting of an RSU received by the Reporting Person dated 2/16/23.